Treatment of Secondary Polycythemia in Congenital Cyanotic Heart Disease

Secondary polycythemia arising in patients with congenital cyanotic heart disease presents a distinct clinical situation that calls for a management pathway separate from that used in other polycythemia settings.

Clinical Scenario

Patients with congenital cyanotic heart disease are best managed by specialist cardiology clinics. The underlying cardiac physiology in this population creates specific haematological considerations that must be accounted for in any clinical decision.

Management Approach

Care for polycythemia in this population is led by specialist cardiology teams. Decisions regarding certain haematological interventions are subject to specific clinical criteria in this context — the full structured protocol details the criteria and sequencing involved.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/bjh.15647

Patients with congenital cyanotic heart disease are best managed by specialist cardiology clinics.

Decisions about venesection for these patients should not be made in a haematology clinic.

View source ↗